CannIntelligence open content

Podcast: What does the European Court of Justice Kanavape ruling mean for the industry?

Written by CBD-Intel | 25th May 2022

Host Jon Bruford talks to CBD-Intel legal analyst Lorenzo Guaragna about the European Court of Justice Kanavape ruling on CBD vapes, and the wider repercussions of this ruling ...

What action in the name of sustainability is the CBD industry likely to see?

Written by Freddie Dawson | 19th May 2022

CBD is already working from a higher base than many consumer products on the market. But that does not mean there is nothing else to be done ...

EU officially recognises first CBG-rich hemp variety among registered plants

Written by Tiziana Cauli | 13th May 2022

The EU has granted official recognition to a hemp variety rich in cannabigerol (CBG) by including a new cannabinoid strain in its database of registered plant varieties ...

How likely is it that the US will see further delta-8 THC enforcement?

Written by Freddie Dawson | 12th May 2022

The US Food and Drug Administration (FDA) recently sent its first round of letters concerning delta-8 THC to five companies. How likely is it that the US will see further delta-8 THC enforcement? ...

UK FSA updates novel food list – but what difference will it make to the market?

Written by Freddie Dawson | 5th May 2022

The recent update to the UK Food Standards Agency (FSA)’s list of CBD products linked to validated novel food applications has created further issues and questions in the industry – such as, what will actually...

DEA defines cannabis seeds with less than 0.3% THC as hemp and as legal

Written by Tiziana Cauli | 2nd May 2022

The US Drug Enforcement Administration (DEA) has confirmed that cannabis seeds fall outside the realm of the Controlled Substances Act (CSA) – regardless of how much THC the plant could eventually yield ...

Psychedelics and mental health research: hope for public and policy support

Written by Lorraine Mullaney | 27th April 2022

Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many ...

Different strokes for different folks – why the EU’s not all one for wellness CBD

Written by Lorraine Mullaney | 26th April 2022

Companies selling CBD wellness products in the EU must be wary of the lack of harmonisation at the EU level and the potential complications this can bring ...

The common sense of CBD science, and why it doesn’t always come to the fore

Written by Barnaby Page | 21st April 2022

Is the current system of peer-reviewed journal publication the best way to get the best science on CBD and cannabis? There could be another way ...

E-commerce platform Shopify accused of shutting down legal delta-8 THC sales

Written by CannIntelligence | 19th April 2022

US-based CBD shops that used Shopify to support online sales are still dealing with the fallout weeks after the e-commerce platform suddenly removed sites it deemed non-compliant ...

Polish court decision on hemp as novel food could have big ramifications

Written by Freddie Dawson | 14th April 2022

A Polish appeals court has put forward a decision that may be out of kilter with many other interpretations of the status of hemp as a novel food ...

Many high street CBD products must be removed from sale, research shows

Written by JuditBach | 12th April 2022

FOR IMMEDIATE RELEASE Many high street CBD products must be removed from sale, research shows The majority of CBD oral products now on the UK market will have to be removed from sale, significantly affecting...

Will Canadian government’s proposal put renewed fizz in cannabinoid drinks?

Written by Lorraine Mullaney | 6th April 2022

Is the Canadian government’s proposal to increase the number of cannabis-infused drinks that can be legally purchased at one time good news for firms that have invested in cannabinoid-infused beverages? ...

US FDA warns CBD firms over fraudulent and ‘life-threatening’ Covid claims

Written by Tiziana Cauli | 5th April 2022

The US Food and Drug Administration (FDA) has issued warning letters to seven CBD companies for claiming that some of the products they sell may be used to prevent or cure Covid-19 ...

New cannabis-infused drink combines an energy boost with getting high

Written by Lorraine Mullaney | 1st April 2022

A new cannabis-infused energy drink targets consumers who want to combine their workouts with getting high ...

Through a glass darkly – CHUMP aims to spread a little post-Brexit light on CBD

Written by CannIntelligence | 1st April 2022

UK authorities moved today (1st April) to give new clarity on the legal status of CBD and other cannabinoids, with a new department ready to clear up Home Office mess ...

Israeli companies predict a bright future in plants following regulatory changes

Written by Lorraine Mullaney | 28th March 2022

Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids ...

Are there lessons for cannabinoids from the new synthetic-nicotine regulation?

Written by Freddie Dawson | 24th March 2022

Could the cannabinoid industry learn anything from the recent move to close the loophole that had kept synthetic nicotine out of US Food and Drug Administration oversight? ...

Another sign of mainstream acceptance as Amazon gets on board with CBD in US

Written by Freddie Dawson | 21st March 2022

Interest from major players in traditional retail channels continues to grow ...

South Dakota in the US passes legislation making delta-8 THC legal for adult use

Written by CannIntelligence | 14th March 2022

South Dakota’s Republican governor, Kristi Noem, has signed House Bill (HB) 1292, legalising the sale of delta-8 THC, THC-O acetate, and hexahydrocannabinol (HHC) in the state after the bill flew through the state legislature almost...